89BIO INC
HQ - San Francisco, CA
Summary
89bio is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for liver and metabolic diseases
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 2.56 B
Avg. Deal Size£ 2.56 B
Senior Management
Rohan Palekar
CEO
Ryan Martins
CFO
Annie Chang
VP of Investor Relations and Corporate Communications
All rights reserved. Copyright © 2025 Datasite